<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-144052</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Acetylsalicylic acid desensitization in the new era of percutaneous coronary intervention</dc:title>
<dc:description xml:lang="en">Dual antiplatelet therapy is essential in patients undergoing percutaneous coronary intervention with stent implantation. Hypersensitivity to acetylsalicylic acid (ASA) limits treatment options. Desensitization to ASA has classically been studied in patients with respiratory tract disease. Over the last years, many protocols have been described about ASA desensitization in patients with ischemic heart disease, including acute coronary syndrome and the need for coronary stent implantation. It is important to know the efficacy and safety of ASA desensitization in these patients (AU)</dc:description>
<dc:creator>Calvo Cebollero, Isabel</dc:creator>
<dc:creator>Fuertes Ferre, Georgina</dc:creator>
<dc:creator>Ferrer Gracia, Maria Cruz</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El tratamiento con doble antiagregación plaquetaria es imprescindible en los pacientes que van a ser sometidos a un intervencionismo coronario percutáneo con implante de stent. La hipersensibilidad al ácido acetil salicílico (AAS) limita las posibilidades terapéuticas. La desensibilización al AAS ha sido clásicamente estudiada en pacientes con enfermedad del tracto respiratorio. En los últimos años se han descrito varios protocolos de desensibilización en pacientes con cardiopatía isquémica, incluyendo el síndrome coronario agudo y la necesidad de implante de stent coronario. Es importante conocer la eficacia y seguridad de la desensibilización al AAS en estos pacientes (AU)</dc:description>
<dc:source>Med. clín (Ed. impr.);145(6): 253-257, sept. 2015. tab</dc:source>
<dc:identifier>ibc-144052</dc:identifier>
<dc:title xml:lang="es">Desensibilización al ácido acetil salicílico en la nueva era del intervencionismo coronario percutáneo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28158^s22044</dc:subject>
<dc:subject>^d27951^s22078</dc:subject>
<dc:subject>^d3894</dc:subject>
<dc:subject>^d23275^s22074</dc:subject>
<dc:subject>^d27977</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d4404^s22016</dc:subject>
<dc:subject>^d811</dc:subject>
<dc:subject>^d52613^s22057</dc:subject>
<dc:subject>^d24885</dc:subject>
<dc:subject>^d721</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d30650^s22057</dc:subject>
<dc:subject>^d55037^s22020</dc:subject>
<dc:subject>^d12551</dc:subject>
<dc:subject>^d14983</dc:subject>
<dc:subject>^d27938^s22020</dc:subject>
<dc:subject>^d29373^s22020</dc:subject>
<dc:subject>^d27951^s22073</dc:subject>
<dc:subject>^d27951^s22020</dc:subject>
<dc:type>article</dc:type>
<dc:date>201509</dc:date>
</metadata>
</record>
</ibecs-document>
